Back

Curcumin

anti-inflammatory and antioxidant properties

Evidence · Grade B
Meta-analysis availableSystematic review availableHuman trial evidenceTraditional useInteraction risk

Curcumin, the active compound in turmeric, is recognized for its potential anti-inflammatory and antioxidant properties, with ongoing research exploring its health benefits.

Curcumin, the active compound in turmeric, has been investigated for its potential to alleviate symptoms and progression of endometriosis due to its anti-inflammatory and antioxidant properties. Research suggests it may influence several pathways involved in the development and maintenance of endometrial lesions.

Quick answer

What it is: Curcumin, the active compound in turmeric, has been investigated for its potential to alleviate symptoms and progression of endometriosis due to its anti-inflammatory and antioxidant properties.

May support:Lupus (SLE), Endometriosis, Parkinson's Disease, Acid Reflux (GERD), Tendinitis, Hyperthyroidism, GERD, Ulcerative Colitis, Inflammatory Bowel Disease, Depression, Mold Illness / CIRS

Evidence:Evidence · Grade B

Evidence Summary

Evidence · Grade B

Given the absence of specific PubMed studies provided for this request, the evidence grade for curcumin's efficacy in treating specific ailments is considered preliminary. General knowledge suggests that much of the existing research consists of in vitro studies, animal models, and a limited number of human clinical trials, often with small sample sizes or methodological limitations. Therefore, strong clinical evidence for many of its purported benefits is still developing.

Last reviewed · Jun 2026

Have you tried Curcumin?

Vote in 5 seconds. Add details if you want.

Your experience for Lupus (SLE):

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Curcumin

Search on Reddit →

Latest News

Latest news on Curcumin

More on Google News →

Health Videos

Health videos on Curcumin

More on YouTube

Why It Works

Curcumin demonstrates anti-inflammatory effects by inhibiting NF-κB signaling, a key regulator of inflammatory responses, and by reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6. It also modulates angiogenesis by downregulating VEGF expression, potentially limiting the blood supply to endometrial implants, and induces apoptosis in aberrant endometrial cells.

How it works in more detail

Curcumin's potential mechanisms of action are complex and involve interactions with various molecular targets. It has been observed to inhibit the activity of several inflammatory mediators, including NF-κB, COX-2, and LOX. Additionally, curcumin may influence cytokine production, such as TNF-α, IL-1β, and IL-6. Its antioxidant properties are attributed to its ability to scavenge free radicals and enhance the activity of endogenous antioxidant enzymes like superoxide dismutase and glutathione peroxidase. These actions collectively contribute to its observed anti-inflammatory and antioxidant effects.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
400-1200 mg per day of standardized curcumin extract, often in formulations designed for enhanced bioavailability, taken with food.
Research dosage range
Research studies have used a wide range of dosages, from 80 mg to 12,000 mg per day, depending on the condition being studied and the formulation used.
Typical onset
The onset of effects can vary widely depending on the condition, dosage, and individual, but some effects may be observed within weeks of consistent use.
Typical forms
Capsule, Tablet, Powder, Liquid extract
Quality markers
Look for supplements standardized to contain a high percentage of curcuminoids (e.g., 95%). Products that include bioavailability enhancers like piperine (black pepper extract) or are formulated with liposomes or nanoparticles may offer improved absorption.
Medication interactions
  • Anticoagulants (blood thinners)
  • Antiplatelet drugs
  • NSAIDs
  • Diabetes medications
  • Stomach acid reducers (e.g., PPIs, H2 blockers)
Avoid if
  • Gallstones or bile duct obstruction
  • Bleeding disorders
  • Pregnant or breastfeeding (high doses)
  • Planning surgery

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

400-1200 mg per day of standardized curcumin extract, often in formulations designed for enhanced bioavailability, taken with food.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin)

Traditional use

Turmeric, from which curcumin is derived, has been a staple in Ayurvedic and Traditional Chinese Medicine for thousands of years. It has been traditionally used for a wide array of conditions, including inflammatory diseases, digestive issues, skin conditions, and wound healing, and as a general tonic.

Safety

Safety warnings

Generally well-tolerated, but high doses may lead to gastrointestinal upset, nausea, or diarrhea. It may also thin the blood.

Avoid if

  • Gallstones or bile duct obstruction
  • Bleeding disorders
  • Pregnant or breastfeeding (high doses)
  • Planning surgery

Medication interactions

  • Anticoagulants (blood thinners)
  • Antiplatelet drugs
  • NSAIDs
  • Diabetes medications
  • Stomach acid reducers (e.g., PPIs, H2 blockers)

Reported side effects

  • Gastrointestinal upset
  • Diarrhea
  • Nausea
  • Headache
  • Skin rash (rare)

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (B)

Given the absence of specific PubMed studies provided for this request, the evidence grade for curcumin's efficacy in treating specific ailments is considered preliminary. General knowledge suggests that much of the existing research consists of in vitro studies, animal models, and a limited number of human clinical trials, often with small sample sizes or methodological limitations. Therefore, strong clinical evidence for many of its purported benefits is still developing.

Filter by source type

Meta-Analyses(9)

Pooled analyses across multiple human trials.

Very High Quality
  • The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: a systematic review and network meta-analysis.

    Zhao G, Fan Y, Li R, Huang Y, Li W, Zhao Y · Reproductive biology and endocrinology : RB&E · 2025 · n=501

    Nutritional supplements are known to ameliorate polycystic ovary syndrome (PCOS) and have been shown to modulate endocrine and metabolic markers, oxidative stress markers and inflammatory biomarkers in patients with PCOS. A variety of nutritional supplements have been applied in clinics, but a more comprehensive ranking of their efficacy has not yet been investigated. To assess the comparative effectiveness of nutritional supplements in women with PCOS. A systematic search was conducted across PubMed, EMBASE, Web of Science, and the Cochrane Library for randomized controlled trials (RCTs) that met the inclusion criteria up to October 12, 2023. We performed a network meta-analysis (NMA) to evaluate the effectiveness of various nutritional supplements on different indicators of PCOS by synthesizing both direct and indirect evidence from the trials. Seventy-nine RCTs involving 5,501 participants were enrolled in the NMA. It suggested that chromium was notably effective in improving fol

    Meta-AnalysisPubMedVery High Quality
  • Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.

    Zeng L, Yang T, Yang K, Yu G, Li J, Xiang W · Frontiers in immunology · 2022

    To evaluate the randomized controlled trials (RCTs) of Curcumin and Curcuma longa Extract in the treatment of autoimmune diseases. Databases such as Embase, Web of Science, PubMed and The Cochrane Library were searched from the database establishment to February 2022 to collect RCTs of Curcumin and Curcuma longa Extract in the treatment of autoimmune diseases. Then the literature was screened and the data were extracted. Meta-analysis was performed using RevMan 5.3 software. A total of 34 records were included, involving 31 RCTs and 10 types of autoimmune disease. Among them, ankylosing spondylitis (AS) involves one RCT, Behcet 's disease (BD) involves one RCT, Crohn 's disease involves two RCTs, multiple sclerosis (MS) involves two RCTs, oral lichen planus involves six RCTs, psoriasis involves two RCTs, rheumatoid arthritis (RA) involves five RCTs, systemic lupus erythematosus (SLE) involves two RCTs, arteritis involves one RCT, ulcerative colitis (UC) involves nine RCTs. Among them

    Meta-AnalysisPubMedVery High Quality
  • Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.

    Yang K, Chen J, Zhang T, Yuan X, Ge A, Wang S · Frontiers in immunology · 2022 · n=173

    Dietary polyphenol treatment of non-alcoholic fatty liver disease (NAFLD) is a novel direction, and the existing clinical studies have little effective evidence for its therapeutic effect, and some studies have inconsistent results. The effectiveness of dietary polyphenols in the treatment of NAFLD is still controversial. The aim of this study was to evaluate the therapeutic efficacy of oral dietary polyphenols in patients with NAFLD. The literature (both Chinese and English) published before 30 April 2022 in PubMed, Cochrane, Medline, CNKI, and other databases on the treatment of NAFLD with dietary polyphenols was searched. Manual screening, quality assessment, and data extraction of search results were conducted strictly according to the inclusion and exclusion criteria. RevMan 5.3 software was used to perform the meta-analysis. The RCTs included in this study involved dietary supplementation with eight polyphenols (curcumin, resveratrol, naringenin, anthocyanin, hesperidin, catech

    Meta-AnalysisPubMedVery High Quality

Systematic Reviews(6)

Structured reviews of the full body of evidence (incl. Cochrane).

Very High Quality
  • Complementary and Alternative Therapies for Psoriasis.

    Chalupczak NV, Lio PA · Archives of dermatological research · 2024

    Despite recent advancements in psoriasis treatment, challenges in management persist. Recently, there has been a rising interest amongst patients in complementary and alternative medicines (CAM), driven by the desire for more natural, holistic approaches and dissatisfaction with conventional treatments. Up to 41% of patients with psoriasis reported using alternative therapies and 39.5% use complementary therapies (Murphy EC, Nussbaum D, Prussick R, Friedman AJ (2019) Use of complementary and alternative medicine by patients with psoriasis. J Am Acad Dermatol 81:280-283). Despite their rapidly growing prevalence, literature on CAM therapies for psoriasis is lacking, making their recommendation difficult. Since the last systematic review on this topic published in 2018, evidence for new alternative therapies has emerged, promoting a further investigation of their efficacy (Gamret AC, Price A, Fertig RM, Lev-Tov H, Nichols AJ (2018) Complementary and Alternative Medicine Therapies for Pso

    Systematic ReviewPubMedVery High Quality
  • Interventions for preventing the progression of autosomal dominant polycystic kidney disease.

    St Pierre K, Cashmore BA, Bolignano D, Zoccali C, Ruospo M, Craig JC · The Cochrane database of systematic reviews · 2024 · n=8016

    Autosomal dominant polycystic kidney disease (ADPKD) is the leading inherited cause of kidney disease. Clinical management has historically focused on symptom control and reducing associated complications. Improved understanding of the molecular and cellular mechanisms involved in kidney cyst growth and disease progression has resulted in new pharmaceutical agents targeting disease pathogenesis and preventing disease progression. However, the role of disease-modifying agents for all people with ADPKD is unclear. This is an update of a review first published in 2015. We aimed to evaluate the benefits and harms of interventions to prevent the progression of ADPKD and the safety based on patient-important endpoints, defined by the Standardised Outcomes in NephroloGy-Polycystic Kidney Disease (SONG-PKD) core outcome set, and general and specific adverse effects. We searched the Cochrane Kidney and Transplants Register of Studies up to 13 August 2024 through contact with the Information S

    Systematic ReviewPubMedVery High Quality
  • Polyphenol Intervention Ameliorates Non-Alcoholic Fatty Liver Disease: An Updated Comprehensive Systematic Review.

    Ranneh Y, Bedir AS, Abu-Elsaoud AM, Al Raish S · Nutrients · 2024

    Non-alcoholic fatty liver disease (NAFLD) has recently emerged as a challenging metabolic disorder with a strong emphasis on its prevention and management. Polyphenols, a group of naturally occurring plant compounds, have been associated with a decreased risk of various metabolic disorders related to NAFLD. The current systematic review aims to critically assess evidence about the ameliorative effect of polyphenol supplementation on NAFLD patients. A PRISMA systematic search appraisal was conducted in PubMed, Scopus, Web of Science Core Collection, and all relevant studies published prior to April 2024 and met the inclusion criteria were included. Twenty-nine randomized clinical trials (RCTs) comprised 1840 NAFLD patients. The studies primarily examined eleven phenolic compounds, including turmeric, curcumin, resveratrol, genistein, catechin, green tea extract, hesperidin, and silymarin. Turmeric and curcumin decreased liver enzymes, inflammatory cytokines, lipid profile, insulin resis

    Systematic ReviewPubMedVery High Quality

Randomized Human Trials(5)

Controlled human studies with random assignment.

High Quality
  • Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.

    Erol Doğan Ö, Karaca Çelik KE, Baş M, Alan EH, Çağın YF · Nutrients · 2024

    This study aimed to investigate the effects of the Mediterranean diet (MD), combined with curcumin and resveratrol supplementation, on disease activity, serum inflammatory markers, and quality of life in patients with mild-to-moderate active ulcerative colitis (UC). This study was designed as a prospective multicenter three-arm randomized controlled trial. Participants were randomized to the MD, MD + curcumin, and MD + resveratrol groups. All participants were placed on the MD for 8 weeks. The MD + curcumin group also received 1600 mg/day of curcumin supplementation, whereas the MD + resveratrol group received 500 mg/day of resveratrol supplementation for 8 weeks. Anthropometric measurements, Truelove-Witts Index, Short Form-36, Inflammatory Bowel Disease Questionnaire, Mediterranean Diet Adherence Scale (MEDAS), and laboratory tests were performed at baseline and postintervention. Within-group comparisons showed that MD, MD + curcumin, and MD + resveratrol interventions were effective

    Randomized TrialPubMedHigh Quality
  • Short-term influence of Immufen™ on mild allergic rhinitis: a randomized, double-blind, placebo-controlled study.

    K M, Aryan MK, Prabhakaran P, Mulakal JN, Das S S, Im K · Frontiers in allergy · 2024

    Allergic rhinitis (AR) is an IgE-mediated reaction to inhaled allergens, and is a prominent health concern affecting approximately 400 million people worldwide. A comprehensive understanding of AR's pathophysiology is imperative for developing novel therapies, especially considering its frequent co-morbidity with asthma and conjunctivitis. The escalating prevalence of AR is correlated with increased urbanization and environmental pollutants, recognized as prominent contributing factors. Dysregulation in immune networks, Th1/Th2 cytokine imbalance, activation of mast cells and eosinophils are implicated in AR progression. Classic AR symptoms include nasal congestion, nasal itching, rhinorrhea, and sneezing which significantly impact the quality of life, social interactions, and workplace productivity. This randomized, double-blind, placebo-controlled, three-arm, three-sequence study was aimed to assess the efficacy of supplementation of a co-delivery form of turmeric extract with ashwa

    Randomized TrialPubMedHigh Quality
  • Effect of curcumin on inflammatory biomarkers and iron profile in patients with premenstrual syndrome and dysmenorrhea: A randomized controlled trial.

    Talebpour A, Mohammadifard M, Zare Feyzabadi R, Mahmoudzadeh S, Rezapour H, Saharkhiz M · Physiological reports · 2023 · n=76

    Premenstrual syndrome (PMS) and primary dysmenorrhea are common gynecological problems and inflammation may have a role in their etiology. Curcumin is a polyphenolic natural product for which there is increasing evidence of anti-inflammatory and iron chelation effects. This study assessed the effects of curcumin on inflammatory biomarkers and iron profile in young women with PMS and dysmenorrhea. A sample of 76 patients was included in this triple-blind, placebo-controlled clinical trial. Participants were randomly allocated to curcumin (n = 38) and control groups (n = 38). Each participant received one capsule (500 mg of curcuminoid+ piperine, or placebo) daily, from 7 days before until 3 days after menstruation for three consecutive menstrual cycles. Serum iron, ferritin, total iron-binding capacity (TIBC) and high-sensitivity C-reactive protein (hsCRP), as well as white blood cell, lymphocyte, neutrophil, platelet counts, mean platele

    Randomized TrialPubMedHigh Quality

Observational Studies(15)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • Dietary therapy for small bowel Crohn's disease.

    Baharad Y, Engel T, Ben-Horin S · Current opinion in gastroenterology · 2026

    This review highlights the emerging role of dietary interventions for Crohn's disease (CD). An overview of clinical data on dietary strategies for management of CD is presented, including exclusive enteral nutrition, the Crohn's disease exclusion diet (CDED) and the Mediterranean diet, among others. The methodological challenges in performing dietary randomized trials are outlined, including the difficulty in blinding, the multiple components inherent to food interventions and the heterogeneous nature of even 'similar' dietary constituents, collectively making it hard to delineate the responsible mechanism for any observed effect. We also review the data on food supplements explored for this CD treatment, such as vitamin D, omega-3 and combination curcumin-QingDai (CurQD). Novel strategies to integrate personalized nutrition with pharmacologic therapy are discussed and may ultimately improve disease control and patients' long term prognosis and quality of life. Dietary interventions a

    Observational StudyPubMedLow Quality
  • Dietary Bioactive Compounds and Their Role in Allergy Prevention: A Comprehensive Review.

    Zafrilla P, Ballester P, Victoria-Montesinos D, Cerdá B, Marhuenda J, Arcusa R · Nutrients · 2025

    Background/Objectives: Allergic diseases are highly prevalent worldwide and represent a significant public health burden. Current therapies mainly alleviate symptoms without addressing underlying immune dysfunction, which has increased interest in nutritional bioactive compounds as preventive or modulatory agents. This review summarizes evidence on omega-3 polyunsaturated fatty acids, vitamin D, curcumin, ginger bioactives, quercetin, and epigallocatechin gallate (EGCG) in allergy prevention and management. Methods: A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science up to July 2025, including preclinical and clinical studies reporting immunological, mechanistic, and clinical outcomes. Results: Omega-3 fatty acids modulate Th2 responses, promote regulatory T cells, and generate specialized pro-resolving mediators, with modest clinical benefits observed in pregnancy and early life. Vitamin D contributes to immune tolerance and epithelial integrity, alth

    Observational StudyPubMedLow Quality
  • Exploring the therapeutic potential of nutraceutical compounds (Curcumin, Quercetin, Epa, Zinc, and Vitamin D) in managing Celiac disease: insights from cellular mechanisms.

    Jahdkaran M, Asri N, Houri H, Baghaei K, Esmaily H, Sapone A · Molecular biology reports · 2025

    The primary treatment for Celiac disease (CeD) is a gluten-free diet (GFD), which presents challenges. Studies on the anti-inflammatory properties of Curcumin, Quercetin, Vitamin D, Zinc, and Eicosapentaenoic acid (EPA) offer hope for patients. This study evaluated their effects on immune reactivity in gliadin-stimulated Caco-2 cells. Cells were treated with pepsin trypsin-digested gliadin (PT-G) and exposed to these compounds individually and in combinations using the n-1 method. Gene expressions of TNF-α, NF-κB, STAT-3, ZO-1, and Occludin were analyzed via qPCR, while IL-6 and IL-10 protein levels were measured using ELISA. Results showed a significant decrease in NF-κB gene expression for Curcumin (P < 0.01), Quercetin (P < 0.001), Vitamin D (P < 0.01), Zinc (P < 0.01), EPA (P < 0.001), and CQEDZ (P < 0.05). IL-6 levels increased significantly with Curcumin (P&#x2

    Observational StudyPubMedLow Quality

Animal Studies(2)

Preclinical animal research — not a substitute for human evidence.

Low Quality
  • Effectiveness of topical intranasal curcumin in the experimentally induced allergic rhinitis model in rats (revised).

    Demir E, Koten M, Keskin FEU, Eryıldız C, Güven SG · Allergologia et immunopathologia · 2026

    Curcumin, a flavonoid derived from turmeric, has demonstrated antioxidant, anti-inflammatory, and antiallergic effects. This study evaluated the therapeutic efficacy of intranasal curcumin in an allergic rhinitis (AR) rat model. Forty rats were randomized into four groups: a sham control, an AR model with no treatment (negative control), an AR model treated with intranasal mometasone furoate (positive control), and an AR model treated with intranasal curcumin. Allergic symptoms (sneezing, itching, nasal discharge) were evaluated by both unblinded and blinded observers. Serum Ovalbumin (OVA)-specific IgE levels were measured using ELISA. Nasal mucosal histopathology (edema, cilia loss, goblet cell hyperplasia, inflammation, eosinophilia) was assessed by light microscopy. Intranasal curcumin significantly improved histopathological findings and reduced allergic symptoms, with efficacy comparable to steroid treatment. It alleviates AR symptoms and inflammation, suggesting a promising, low

    Animal StudyPubMedLow Quality
  • Effectiveness of topical intranasal curcumin in the experimentally induced allergic rhinitis model in rats.

    Demir E, Koten M, Keskin FEU, Eryıldız C, Güven SG · Allergologia et immunopathologia · 2026

    Curcumin, a flavonoid derived from turmeric, has demonstrated antioxidant, anti-inflammatory, and anti-allergic effects. This study evaluated the therapeutic efficacy of intranasal curcumin in an allergic rhinitis (AR) rat model. Forty rats were randomized into five groups: a Sham control, an AR model with no treatment (negative control), an AR model treated with intranasal mometasone furoate (positive control), and an AR model treated with intranasal curcumin. Allergic symptoms (sneezing, itching, nasal discharge) were evaluated by both unblinded and blinded observers. Serum ovalbumin (OVA)-specific IgE levels were measured using ELISA. Nasal mucosal histopathology (edema, cilia loss, goblet cell hyperplasia, inflammation, eosinophilia) was assessed by light microscopy. Intranasal curcumin significantly improved histopathological findings and reduced allergic symptoms, with efficacy comparable to steroid treatment. Intranasal curcumin alleviated allergic rhinitis symptoms and inflamma

    Animal StudyPubMedLow Quality

Clinical Trial Registries(9)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • KurCoSmart Effects on People With Type 2 DM: a Randomized, Open Trial

    n=40 · NCT05407467 · UNKNOWN · UNKNOWN

    The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and insulin resistance evaluation

    Clinical TrialClinicalTrials.govModerate Quality
  • The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato

    n=60 · NCT05975866 · UNKNOWN · UNKNOWN

    The goal of this clinical trial is to investigate The effects of an anti-inflammatory diet with or without curcumin supplementation on anthropometric measurements, concentrations of thyroid hormones, anti-TPO, and systemic inflammation in plasma and NFK-B in peripheral blood mononuclear cells in patients with Hashimoto. The main questions it aims to answer are: 1. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in anthropometric measurements (weight, body mass index, BMI, waist circumference, waist-to-hip ratio) in patients with Hashimoto's disease? 2. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in the serum concentration of thyroid hormones (T3, T4, TSH) in patients with Hashimoto's disease? 3. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the change of Anti-TPO concentration in patients with Hashimoto's disease? 4. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in systemic inflammation indicators (hs-CRP, IL-6) in plasma and NF-κB in peripheral blood mononuclear cells in patients with Hashimoto's disease?

    Clinical TrialClinicalTrials.govModerate Quality
  • Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome

    n=15 · NCT03542240 · COMPLETED · COMPLETED

    This study will investigate the effects of curcumin on the structure/function of the body by investigating whether targeted improvement of intestinal barrier function by supplementation with oral curcumin will result in attenuation of lipopolysaccharide (LPS) translocation and/or intestinal inflammation.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: The primary limitation is the lack of specific, high-quality human clinical trials for many of the linked ailments. Many studies are preclinical or pilot studies, which do not provide sufficient evidence for definitive conclusions. Bioavailability of curcumin is also a known challenge, which can impact the interpretation of study results.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Curcumin?

Help others see what actually works.